Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study
- 6 August 2019
- journal article
- research article
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 23 (9) , 831-842
Abstract
An organ-preserving strategy may be a valid alternative in the treatment of selected patients with rectal cancer after neoadjuvant radiotherapy. Preoperative assessment of the risk for tumor recurrence is a key component of surgical planning. The aim of the present study was to increase the current knowledge on the risk factors for tumor recurrence. The present study included individual participant data of published studies on rectal cancer surgery. The literature was reviewed according to according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Individual Participant Data checklist (PRISMA-IPD) guidelines. Series of patients, whose data were collected prospectively, having neoadjuvant radiotherapy followed by transanal local excision for rectal cancer were reviewed. Three independent series of univariate/multivariate binary logistic regression models were estimated for the risk of local, systemic and overall recurrence, respectively. We identified 15 studies, and 7 centers provided individual data on 517 patients. The multivariate analysis showed higher local and overall recurrences for ypT3 stage (OR 4.79; 95% CI 2.25-10.16 and OR 6.43 95% CI 3.33-12.42), tumor size after radiotherapy > 10 mm (OR 5.86 95% CI 2.33-14.74 and OR 3.14 95% CI 1.68-5.87), and lack of combined chemotherapy (OR 3.68 95% CI 1.78-7.62 and OR 2.09 95% CI 1.10-3.97), while ypT3 was the only factor correlated with systemic recurrence (OR 5.93). The analysis of survival curves shows that the overall survival is associated with ypT and not with cT. Local excision should be offered with caution after neoadjuvant chemoradiotherapy to selected patients with rectal cancers, who achieved a good response to neoadjuvant chemoradiotherapy.Keywords
This publication has 20 references indexed in Scilit:
- A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit?Colorectal Disease, 2018
- Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trialThe Lancet, 2017
- Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trialThe Lancet Oncology, 2015
- Risk of complications and long-term functional alterations after local excision of rectal tumors with transanal endoscopic microsurgery (TEM)International Journal of Colorectal Disease, 2015
- Nonoperative Management of Rectal CancerHematology/Oncology Clinics of North America, 2015
- Long-term Outcome of Local Excision After Preoperative Chemoradiation for ypT0 Rectal CancerDiseases of the Colon & Rectum, 2014
- Local Excision After Preoperative Chemoradiotherapy for Rectal CancerDiseases of the Colon & Rectum, 2013
- Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: A prospective multicentre studyRadiotherapy and Oncology, 2013
- Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapySurgical Endoscopy, 2009
- A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancerBritish Journal of Surgery, 2009